Switzerland · Series B startup

Who invested in Xigen

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$41Mraised across 2 rounds since 2005, from 2 sources

$21MSeries A$20MSeries B
Latest round
Series B, $20MNov 2009
Biggest round
$21MSeries A · Sept 2005
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2006200720082009
$21MSeries A$20MSeries B
First round
Series A, $21M
Sept 2005
Biggest round
$21M
Series A · Sept 2005
Between rounds
4.2 years
from the last two

The rounds

  1. Nov 2009
    Series B$20M1 returning

    Reported by fiercebiotech.com

  2. Sept 2005

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Tilocor Life ScienceVC firm2rounds
VI PartnersVC firm1round
Initiative CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Xigen

Who invested in Xigen?

Xigen's investors include Tilocor Life Science, VI Partners and Initiative Capital.

How much has Xigen raised?

Xigen has raised $41M across 2 rounds since 2005.

When did Xigen last raise?

Xigen's most recent round was a Series B of $20M in Nov 2009.

What was Xigen's biggest round?

Xigen's largest round on record is $21M (Series A), in Sept 2005.

Who backed Xigen first?

Xigen's first round on record, in Sept 2005, was backed by VI Partners, Tilocor Life Science and Initiative Capital.

What stage is Xigen at?

Xigen's latest named round is a Series B, in Nov 2009.

Where is Xigen based?

Xigen is based in Switzerland.

Companies like Xigen

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.